Checkpoint inhibition: new treatment options in urologic cancer
Author:
Affiliation:
1. Department Medical Oncology, Ghent University Hospital, Ghent, Belgium
2. AZ Sint-Lucas Brugge, Bruges, Belgium
3. Drug Research Unit, Ghent University Hospital, Ghent, Belgium
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17843286.2016.1260890
Reference46 articles.
1. Cancer immunoediting: from immunosurveillance to tumor escape
2. Hallmarks of Cancer: The Next Generation
3. Cancer immunotherapy comes of age
4. The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
5. Molecular Pathways: Next-Generation Immunotherapy—Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic review;Trials;2023-11-06
2. Diagnostic Utility of RNA-Seq for Evaluation of PD-L1 Expression in Clear Cell Renal Cell Carcinoma;Clinical Genitourinary Cancer;2021-12
3. The Significance of INHBE Expression in the Cancer Cells of Clear-Cell Renal Cell Carcinoma;Urologia Internationalis;2021-08-31
4. RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation;Cancer Immunology, Immunotherapy;2021-04-10
5. Increased PD-L1 expression in high-grade bladder cancer with squamous cell differentiation in Bulgarian and French patients' samples;Annals of Diagnostic Pathology;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3